Literature DB >> 8845374

In vitro phosphorylation of the epidermal growth factor receptor autophosphorylation domain by c-src: identification of phosphorylation sites and c-src SH2 domain binding sites.

C R Lombardo1, T G Consler, D B Kassel.   

Abstract

During epidermal growth factor mediated signal transduction, intracellular receptor autophosphorylation on tyrosine residues results in the localization of several SH2 domain bearing proteins, including c-src, to the plasma membrane. This process is part of a complex pathway of specific protein associations that culminates in the regulation of cell growth and mitogenesis. The SH2 domain-mediated interaction of c-src with the EGF receptor has been demonstrated, yet the precise function of c-src in EGF receptor signaling remains unclear. The phosphorylation of EGFR by c-src was studied in order to evaluate the molecular basis for this interaction. The C-terminal autophosphorylation domain of EGFR was extensively phosphorylated by c-src and EGFR kinase activities in vitro as determined by electrospay ionization mass spectrometry. The sites of phosphorylation within the autophosphorylation domain (residues 976-1186) were identified by LC/MS, LC/MS/MS, and Edman sequencing. The majority of the sites identified corresponded to the known autophosphorylation sites of EGFR. Kinetic analyses of site-specific phosphorylation were made combining very fast enzyme digests (< = or 2 min) and high-speed, perfusion chromatography. These studies revealed that Y1086 was phosphorylated to a significantly higher extent by c-src than by EGFR. Additionally, Y1101 was identified as a unique c-src phosphorylation site. The function of these phosphorylation sites with respect SH2 domain interactions was investigated by affinity chromatography/mass spectrometry. A subset of peptides corresponding to the eight possible tyrosine phosphorylation sites within the EGFR autophosphorylation domain was demonstrated to bind to the SH2 domain of c-src. Those which bound to the SH2 domain included peptides derived from EGFR sequences flanking Y992, Y1086, Y1101, and Y1148. These data indicate that specific EGF receptor c-src phosphorylation sites are also ligands for the SH2 domain of c-src. Finally, extensive c-src phosphorylation of EGFR promoted its conversion to a form that exhibits high-affinity (KD = 380 nM) and cooperative (Hill coefficient; n = 2) binding to the SH2 domain of c-src as measured by surface plasmon resonance. The identification of c-src phosphorylation sequences on EGFR as c-src SH2 binding sites supports the notion that this interaction plays a significant role in the regulation of growth factor receptor function and signal transduction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8845374     DOI: 10.1021/bi00050a029

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  21 in total

1.  Loss of Hsp90 association up-regulates Src-dependent ErbB2 activity.

Authors:  Wanping Xu; Xitong Yuan; Kristin Beebe; Zhexin Xiang; Len Neckers
Journal:  Mol Cell Biol       Date:  2006-10-09       Impact factor: 4.272

2.  Performance comparison of three trypsin columns used in liquid chromatography.

Authors:  Tereza Šlechtová; Martin Gilar; Květa Kalíková; Stephanie M Moore; James W Jorgenson; Eva Tesařová
Journal:  J Chromatogr A       Date:  2017-02-14       Impact factor: 4.759

3.  A quantitative study of the recruitment potential of all intracellular tyrosine residues on EGFR, FGFR1 and IGF1R.

Authors:  Alexis Kaushansky; Andrew Gordus; Bryan Chang; John Rush; Gavin MacBeath
Journal:  Mol Biosyst       Date:  2008-04-08

4.  Tyrosine phosphorylation of nicotinic acetylcholine receptor mediates Grb2 binding.

Authors:  M Colledge; S C Froehner
Journal:  J Neurosci       Date:  1997-07-01       Impact factor: 6.167

5.  MAPK scaffold IQGAP1 binds the EGF receptor and modulates its activation.

Authors:  Dean E McNulty; Zhigang Li; Colin D White; David B Sacks; Roland S Annan
Journal:  J Biol Chem       Date:  2011-02-24       Impact factor: 5.157

6.  Met and c-Src cooperate to compensate for loss of epidermal growth factor receptor kinase activity in breast cancer cells.

Authors:  Kelly L Mueller; Lauren A Hunter; Stephen P Ethier; Julie L Boerner
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

7.  Therapeutic IMC-C225 antibody inhibits breast cancer cell invasiveness via Vav2-dependent activation of RhoA GTPase.

Authors:  Poonam R Molli; Liana Adam; Rakesh Kumar
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

8.  Prognostic effect of activated EGFR expression in human colon carcinomas: comparison with EGFR status.

Authors:  R L Rego; N R Foster; T C Smyrk; M Le; M J O'Connell; D J Sargent; H Windschitl; F A Sinicrope
Journal:  Br J Cancer       Date:  2009-12-08       Impact factor: 7.640

9.  Differential phosphoproteomics of fibroblast growth factor signaling: identification of Src family kinase-mediated phosphorylation events.

Authors:  Debbie L Cunningham; Steve M M Sweet; Helen J Cooper; John K Heath
Journal:  J Proteome Res       Date:  2010-05-07       Impact factor: 4.466

10.  20-HETE activates the Raf/MEK/ERK pathway in renal epithelial cells through an EGFR- and c-Src-dependent mechanism.

Authors:  Talha Akbulut; Kevin R Regner; Richard J Roman; Ellis D Avner; John R Falck; Frank Park
Journal:  Am J Physiol Renal Physiol       Date:  2009-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.